Andreas Eschbach, founder and CEO of eschbach, explores how embracing 360° connectivity can break down information silos and help build a ‘visual factory’, offering accurate real-time data and insights, better communication across departments.
Guardtech’s Isopod Rapid Cleanrooms are designed to be quick-assembly controlled environment systems developed to provide flexible cleanroom solutions without permanent structural alterations.
Strengthened by the new EU–India Free Trade Agreement, SpinChem is now expanding its presence in India's pharmaceutical markets through a partnership with Smart Labtech.
Shibuya Corporation highlights its Vial Filling Systems, established aseptic solutions engineered to support reliable performance across multiple products and every stage of pharmaceutical vial preparation and filling.
Sequana Medical has announced strong commercial US progress with implants of the alfapump System having been completed at five centres since launch in Q4 2025.
Quotient Sciences has extended commercial supply partnership with Ipsen to manufacture a treatment for Fibrodysplasia Ossificans Progressiva (FOP), an ultra-rare disease affecting fewer than 1,000 people worldwide.
Following his keynote address at the inaugural York and North Yorkshire Life Sciences Forum at York University’s Biotech campus, Chris Allen, CEO of Broughton, sat down with European Pharmaceutical Manufacturer to expand on the conversation.
Asahi Kasei Pharma announced that it has strengthened its drug discovery pipeline through an exclusive global license agreement regarding novel lead compounds for a single target with Alchemedicine.
Shibuya Hoppmann highlights its FT-40 RD and FT-50 RD Centrifugal Feeders, designed to deliver consistent, high-speed part feeding with durable construction and easy integration into automated production environments.
INTERPHEX WEEK TOKYO 2026, one of Japan’s largest and most influential trade shows for the pharmaceutical and biotechnology sectors, is set to return 20-22nd May at Makuhari Messe with an expanded showcase expected to surpass its 2025 performance.
